In 2022’s second quarter, Pfizer reported July 28 its largest-ever quarterly sales as it racked up $27.7 billion, mostly thanks to its vaccine sales.
Read the full post on Becker's Hospital Review - Healthcare News
Pfizer earned $27.7B in Q2: 3 findings
